Literature DB >> 25015500

Human endogenous retroviruses and the nervous system.

Renée N Douville1, Avindra Nath2.   

Abstract

Entities:  

Keywords:  amyotrophic lateral sclerosis; brain; central nervous system; motor neuron disease; multiple sclerosis; retrovirus; schizophrenia

Mesh:

Year:  2014        PMID: 25015500      PMCID: PMC4903019          DOI: 10.1016/B978-0-444-53488-0.00022-5

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


× No keyword cloud information.
  216 in total

1.  Np9 protein of human endogenous retrovirus K interacts with ligand of numb protein X.

Authors:  Vivienne Armbruester; Marlies Sauter; Klaus Roemer; Barbara Best; Steffen Hahn; Achille Nty; Andreas Schmid; Stephan Philipp; Anja Mueller; Nikolaus Mueller-Lantzsch
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 2.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

3.  Multiple sclerosis. Relationship to a retrovirus?

Authors:  B H Waksman
Journal:  Nature       Date:  1989-02-16       Impact factor: 49.962

Review 4.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.

Authors:  Clotilde Lagier-Tourenne; Magdalini Polymenidou; Don W Cleveland
Journal:  Hum Mol Genet       Date:  2010-04-15       Impact factor: 6.150

5.  Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases.

Authors:  J B Johnston; C Silva; J Holden; K G Warren; A W Clark; C Power
Journal:  Ann Neurol       Date:  2001-10       Impact factor: 10.422

6.  Regulation of human endogenous retrovirus-K expression in melanomas by CpG methylation.

Authors:  Sven Stengel; Uwe Fiebig; Reinhard Kurth; Joachim Denner
Journal:  Genes Chromosomes Cancer       Date:  2010-05       Impact factor: 5.006

7.  Inhibition of multiple-sclerosis-associated retrovirus as biomarker of interferon therapy.

Authors:  Giuseppe Mameli; Caterina Serra; Vito Astone; Massimiliano Castellazzi; Luciana Poddighe; Enrico Fainardi; Walter Neri; Enrico Granieri; Antonina Dolei
Journal:  J Neurovirol       Date:  2008-01       Impact factor: 2.643

8.  Influence of antipsychotic drugs on human endogenous retrovirus (HERV) transcription in brain cells.

Authors:  Olivia Diem; Marisa Schäffner; Wolfgang Seifarth; Christine Leib-Mösch
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

9.  Expression profiling of repetitive elements by melting temperature analysis: variation in HERV-W gag expression across human individuals and tissues.

Authors:  Christoffer Nellåker; Fang Li; Fredrik Uhrzander; Joanna Tyrcha; Håkan Karlsson
Journal:  BMC Genomics       Date:  2009-11-17       Impact factor: 3.969

Review 10.  TRIM family proteins: retroviral restriction and antiviral defence.

Authors:  Sébastien Nisole; Jonathan P Stoye; Ali Saïb
Journal:  Nat Rev Microbiol       Date:  2005-10       Impact factor: 60.633

View more
  13 in total

Review 1.  Role of Exosomes in Human Retroviral Mediated Disorders.

Authors:  Monique Anderson; Fatah Kashanchi; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2018-04-14       Impact factor: 4.147

Review 2.  Up-to-date knowledge about the association between multiple sclerosis and the reactivation of human endogenous retrovirus infections.

Authors:  Borros Arneth
Journal:  J Neurol       Date:  2018-02-08       Impact factor: 4.849

3.  Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors.

Authors:  Paul Dembny; Andrew G Newman; Manvendra Singh; Michael Hinz; Michal Szczepek; Christina Krüger; Robert Adalbert; Omar Dzaye; Thorsten Trimbuch; Thomas Wallach; Gunnar Kleinau; Katja Derkow; Bernhard C Richard; Carola Schipke; Claus Scheidereit; Harald Stachelscheid; Douglas Golenbock; Oliver Peters; Michael Coleman; Frank L Heppner; Patrick Scheerer; Victor Tarabykin; Klemens Ruprecht; Zsuzsanna Izsvák; Jens Mayer; Seija Lehnardt
Journal:  JCI Insight       Date:  2020-04-09

4.  ERVK polyprotein processing and reverse transcriptase expression in human cell line models of neurological disease.

Authors:  Mamneet Manghera; Jennifer Ferguson; Renée Douville
Journal:  Viruses       Date:  2015-01-20       Impact factor: 5.048

5.  Grand Challenges in Neuroinfectious Diseases.

Authors:  Avindra Nath
Journal:  Front Neurol       Date:  2017-09-14       Impact factor: 4.003

Review 6.  HSV-1 and Endogenous Retroviruses as Risk Factors in Demyelination.

Authors:  Raquel Bello-Morales; Sabina Andreu; Inés Ripa; José Antonio López-Guerrero
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

Review 7.  Restricting retrotransposons: a review.

Authors:  John L Goodier
Journal:  Mob DNA       Date:  2016-08-11

8.  High expression of Endogenous Retroviruses from intrauterine life to adulthood in two mouse models of Autism Spectrum Disorders.

Authors:  Chiara Cipriani; Laura Ricceri; Claudia Matteucci; Alessia De Felice; Anna Maria Tartaglione; Ayele Argaw-Denboba; Francesca Pica; Sandro Grelli; Gemma Calamandrei; Paola Sinibaldi Vallebona; Emanuela Balestrieri
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

9.  Analysis of Human Endogenous Retrovirus Expression in Multiple Sclerosis Plaques.

Authors:  P J Bhetariya; J D Kriesel; K F Fischer
Journal:  J Emerg Dis Virol       Date:  2017-07-24

Review 10.  Endogenous Retroviruses: With Us and against Us.

Authors:  Thomas J Meyer; Jimi L Rosenkrantz; Lucia Carbone; Shawn L Chavez
Journal:  Front Chem       Date:  2017-04-07       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.